跳至主要内容
临床试验/NCT07075783
NCT07075783已完成4 期

Comparison of Efficacy of MgSO4 Added to Ropivacaine and Ropivacaine Alone in Scalp Block for Craniotomy: a Randomized Controlled Trial

Hospital Universiti Sains Malaysia1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2024年10月3日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
24
试验地点
1
主要终点
Mean Arterial Pressure

研究概览

简要总结

A randomized, double-blinded controlled trial was conducted to evaluate the analgesic efficacy of MgSO4 as an adjuvant to ropivacaine in scalp blocks for craniotomy, focusing on its impact on hemodynamic parameters and intraoperative remifentanil consumption.

详细描述

A prospective, randomized, double-blinded controlled trial was conducted at Hospital Universiti Sains Malaysia (HUSM). Twenty-four patients scheduled for elective supratentorial craniotomy under general anesthesia were randomized into two groups: the control group (ropivacaine alone) and the treatment group (ropivacaine with MgSO4). Hemodynamic parameters, including mean arterial pressure (MAP) and heart rate (HR), were recorded at seven predefined intraoperative time points corresponding to critical surgical stimuli. Total intraoperative remifentanil consumption was also measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for elective supratentorial craniotomy under general anaesthesia
  • ASA I-III physical status
  • Aged 18 years and above

排除标准

  • Traumatic brain injury
  • Aneurysmal clipping
  • Contraindication to scalp block
  • Known adverse reaction to magnesium sulphate or LA from previous exposure
  • Heart block
  • History of drug dependence or alcohol abuse

研究组 & 干预措施

Control group (RN)

Placebo Comparator

•Control (RN) group: 0.375% Plain Ropivacaine at a maximum recommended dose of 3 mg/kg body weight, plus 5 mcg/ml adrenaline and 1 ml of 0.9% NaCl.

干预措施: Plain Ropivacaine (Other)

Study group (RM)

Experimental

Study (RM) group: 0.375% Plain Ropivacaine at maximum recommended dose of 3 mg/kg body weight, plus 5 mcg/ml adrenaline and 1 ml of 50% MgSo4.

干预措施: MgSO4 plus Ropivacaine (Drug)

结局指标

主要结局

Mean Arterial Pressure

时间窗: Mean arterial blood pressure (MAP) recorded at seven time points: scalp block (T0), skull pin fixation (T1), skin incision (T2), craniotomy (T3), durotomy (T4), dura mater closure (T5) and skin closure (T6)

Heart Rate (HR)

时间窗: Heart Rate (HR) recorded at seven time points: scalp block (T0), skull pin fixation (T1), skin incision (T2), craniotomy (T3), durotomy (T4), dura mater closure (T5) and skin closure (T6)

次要结局

  • Cumulative remifentanil dose(Total intra-operative consumption of remifentanil)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alwyn Lee Chee Yuan

Principal Investigator

Hospital Universiti Sains Malaysia

研究点 (1)

Loading locations...

相似试验